North Alabama Chapter - August Meeting & Dinner
Revivalist
106 Jefferson Street South
Huntsville, AL 35801
Tuesday, August 19, 2025 at 6:30pm CT - 8:30pm CT
Add this event to your calendar
Info
Topic
Terlivaz for Hepatorenal Syndrome in AKI
Attachments
Additional Information
This is our first chapter meeting of the new "year" on the AACN calendar! We will review that great progress our chapter has made last year and our plans to continue that in the coming year. We will introduce the Board of Directors who have stepped up to lead the chapter, and we will hear a presentation from our sponsors at Mallinckrodt Pharmaceuticals about Terlivaz.
Terlivaz is the first FDA-approved treatment for patients with Hepatorenal Syndrome and a rapid reduction in kidney function. This presentation is appropriate for progressive and critical care nurses, providers, educators, and directors.
IMPORTANT! TO REGISTER:
1) Please register as usual on Nursing Network for AACN records.
2) This sponsor also has a registration process for their own records. Please follow the link below or email morgan.sansing@mnk.com to complete registration with Mallinckrodt.
Speakers
System Director, Critical Care Medicine at RWJBarnabas Health and Clinical Professor, Rutgers New Jersey Medical School
Dr. Rezai is the System Director of Critical Care Medicine, RWJBarnabas Health, part of the Emergency and Hospitalist Medicine (EHM) Service Line. He is responsible for ensuring the collaborative, intensivist-driven, Intensive Care Unit (ICU) model is clinically consistent and standardized across the enterprise. Since joining RWJBarnabas Health more than 22 years ago, Dr. Rezai has continually assumed additional clinical and leadership responsibility both at Cooperman Barnabas Medical Center and in the System. Dr. Rezai was integrally involved in creating an intensivist-driven ICU model at Cooperman Barnabas Medical Center, Community Medical Center and Monmouth Medical Center. With a continuous focus on safety and quality, he has implemented numerous processes and protocols that have resulted in superior outcomes for patients. Dr. Rezai is Past President of the Society of Critical Care Medicine, New Jersey Chapter, where he is active both on a local and national level. He is a Fellow of the American College of Critical Care Medicine (FCCM) and a Fellow of the American College of Chest Physicians (FCCP). As an academic leader and tenured professor, Dr. Rezai has more than 200 publications, abstracts, presentations and lectures, and serves as a Clinical Professor at Rutgers, New Jersey Medical School.